about
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESP...
Read More
5.59
-0.03
(-0.53%)
9,484
XNAS Volume
XNAS 23 Jun, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Valneva SE - ADR is on 26 Jun 2025 for the purpose of Valneva SE Annual General Meeting for 2025
See details
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Valneva SE - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..